ctDNA-Guided Therapy in Stage II Colon Cancer | NEJM

4 Views
administrator
administrator
07/07/23

The benefit of adjuvant chemotherapy for stage II colon cancer is unclear. Measuring circulating tumor DNA after surgery might offer guidance as to whether a patient will benefit. New research findings are summarized in a short video.

To see the full article, follow this link: https://nej.md/3x0jR94

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next